PRAC meeting highlights 28-31 October 2024

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

The current PRAC highlights from the Oct 2024 meeting outlines the broad range of responsibilities conducted by the committee during the monthly meeting. The Committee did not start or conclude any referral procedures.